A phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C adeno-associated virus vaccine.

Source:http://linkedlifedata.com/resource/pubmed/id/18544020

Download in:

View as

General Info

PMID
18544020